- Home
- NITO vs EVGN Comparison
NITO vs EVGN Comparison
Compare NITO & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NITO
- EVGN
- Stock Information
- Founded
- NITO 2009
- EVGN 1999
- Country
- NITO Israel
- EVGN Israel
- Employees
- NITO N/A
- EVGN N/A
- Industry
- NITO
- EVGN Agricultural Chemicals
- Sector
- NITO
- EVGN Industrials
- Exchange
- NITO NYSE
- EVGN Nasdaq
- Market Cap
- NITO 7.8M
- EVGN 7.3M
- IPO Year
- NITO N/A
- EVGN N/A
- Fundamental
- Price
- NITO $0.24
- EVGN $1.28
- Analyst Decision
- NITO
- EVGN Strong Buy
- Analyst Count
- NITO 0
- EVGN 1
- Target Price
- NITO N/A
- EVGN $3.50
- AVG Volume (30 Days)
- NITO 1.2M
- EVGN 5.5M
- Earning Date
- NITO 08-13-2025
- EVGN 08-21-2025
- Dividend Yield
- NITO N/A
- EVGN N/A
- EPS Growth
- NITO N/A
- EVGN N/A
- EPS
- NITO N/A
- EVGN N/A
- Revenue
- NITO $232,000.00
- EVGN $6,765,000.00
- Revenue This Year
- NITO N/A
- EVGN N/A
- Revenue Next Year
- NITO N/A
- EVGN $113.18
- P/E Ratio
- NITO N/A
- EVGN N/A
- Revenue Growth
- NITO 24.74
- EVGN N/A
- 52 Week Low
- NITO $0.16
- EVGN $0.95
- 52 Week High
- NITO $3.49
- EVGN $7.19
- Technical
- Relative Strength Index (RSI)
- NITO 42.39
- EVGN 47.33
- Support Level
- NITO $0.23
- EVGN $1.34
- Resistance Level
- NITO $0.26
- EVGN $1.63
- Average True Range (ATR)
- NITO 0.02
- EVGN 0.16
- MACD
- NITO -0.00
- EVGN -0.02
- Stochastic Oscillator
- NITO 14.95
- EVGN 15.56
About NITO N2OFF INC
N2OFF Inc is a pioneering agri-food tech company dedicated to developing sustainable solutions for the plant-based food industry. Operating through two subsidiaries, it delivers integrated solutions for enhanced safety, quality, and sustainability from field to fork. The Company has two reportable segments: Pathogen prevention and prolong shelf life, and the N2O emissions Global warming solutions.
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.